Quantitative structure - Activity relationship (QSAR) studies on non steroidal anti-inflammatory drugs (NSAIDs)

Current Medicinal Chemistry

Volumn 7, Issue 4, 2000, Pages 375-388

  Hadjipavlou Litina, Dimitra ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIINFLAMMATORY ACTIVITY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; INFLAMMATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

EID: 0034086105     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867003375128     Document Type: Review

References (48)

1. Vane, J.; Nature, 1994, 367, 215.
2. Kujubu, D.A.; Fletcher, B.C.; Varnun, C.; Lim, R.W.; Herschman, H.; J. Biol. Chem., 1991, 266, 12866.
3. Fantone, J.C.; Ward, P.A.; Amer. J. Pathol, 1982, 107, 395; Halliwell, B.; Hoult, J.R.; Blake, D.R.; FASEB J. 1988, 2, 2867.
4. Fantone, J.C.; Ward, P.A.; Amer. J. Pathol, 1982, 107, 395; Halliwell, B.; Hoult, J.R.; Blake, D.R.; FASEB J. 1988, 2, 2867.
5. Oyanagui, Y.; Biochem. Pharmacol. 1976, 25, 1465.
6. Yoshikawa, T.; Tanaka, H.; Kondo, M.; Biochem. Med. 1985, 33, 320.
7. Lazer, S.E.; Wong, H.C.; Possanza, G.J.; Graham, A.G.; Farina, P.F.; J. Med. Chem. 1989, 32, 100.
8. Lunger, P.; Daneck, K.; Engel, W.; Tnimmalitz, G.; Wagner, K.; Eur. J. Pharm. Sci., 1996, 4, 175.
9. Moser, P.; Sallmann, A.; Wiesenberg, I. J. Med. Chem. 1990, 33, 2358.
10. Summers, J.; Kim, H.K.; Mazdiyasni, H.; Carter, G.; Ratajczyk, J.; Stewart, A.; Dyer, R.; Carter, G.; J. Med. Chem. 1990, 33, 992.
11. Naito, Y.; Sugiura, M.; Yamaura, Y.; Fukaya, C.; Yokoyama, K.; Nakagawa, Y.; Ikeda, T.; Senda, M.; Fujita, T.; Chem. Pharm. Bull. 1991, 39, 1736.
12. Mitsuda, H.; Yasumoto, K.; Yamamoto, A.; Arch. Biochem. Biophys. 1967, 118, 664.
13. Kim, K.H.; Martin, Y.C.; Brooks, D.W.; Dyer, D.R.; Carter, W.G.; J. Pharm. Sci. 1994, 83, 433.
14. Kim, K.H.; Martin, Y.C.; Brooks, C.D.W.; Quant. Struct.- Act. Relat. 1996, 15, 491.
15. Hansch, C.; Leo, A. J.; In : Substituents Constants for correlation analysis in Chemistry and Biology, 1979, J. Wiley & Sons, New York, p13-63.
16. Geronikaki, A.; Hadjipavlou-Litina, D.; Pharmazie, 1993, 48, 948.
17. Geronikaki, A.; Hadjipavlou-Litina, D.;, Arzneim. Forsch./Drug Res., 1996, 46, 1134.
18. Hadjipavlou-Litina, D.; Res. Commun. Mol. Pathol. Pharmacol. 1997, 95, 319.
19. Hadjipavlou-Litina, D.; Geronikaki, A.; Drug Design Discovery, 1998, 15, 199.
20. Lands, W.E.; 1985; In : Advances in Drug Research, Academic Press Inc. (London) Ltd., vol. 14, p. 147.
21. Saldanha, L.A.; Elias, G.; Rao, M.N.A.; Arzneim. Forsch./Drug Res., 1990, 40, 89.
22. Hadjipavlou-Litina, D.; Nicolaides, D.; Fylaklakidou, K.; Litinas, K.; 1996, Abstracts, 11th European symposium on QSAR, Lausanne, P8A.
23. Hansch, C.; Leo, A.J.; Taft, R.W.; Chem. Rev. 1991, 91, 165.
24. Verloop, A.; Hoogenstraaten, W.; Tipker, J.; 1976, In : Drug Design, ed. Ariens, E.J. Academic Press, New York, Vol. 7, 165.
25. Ruiz, J.; Perez, A.; Pouplana, R.; Quant. Struct. - Act. Relat. 1996, 15, 219.
26. Van de Berg, C.; Bulstma, T.; Nauta, W. T.; Biochem. Pharmacol. 1975, 24, 1115.
27. Franke, R.; 1984; In : Theoretical Drug Design Methods, Elsevier, Pharmacochemistry Library, Vol. 7, 215.
28. Winiwarter, S.; Roth, H.J.; Pharm. Acta Helv. 1994, 68, 181.
29. Humes, J.L.; Winter, C. A.; Sadowski, S. J.; Kuehl, F. A.; Proc. Natl. Acad. Sci. USA, 78, 2053.
30. Wilkerson, W.w.; Galbraith, W.; ganbrags, K.; Grubb, M.; Hewes, W.E.; Jaffee, B.; Kenney, J.P.; Wong, N.; J. Med. Chem. 1994, 37, 988.
31. Tanaka, A.; Yakushiji, K.; Yoshina, S.; J. Heterocycl. Chem. 1977, 14, 975.
32. Swain, C.G.; Unger, S.H.; Rosenquist, N.R.; Swain, M.S.; J. Amer. Chem. Soc. 1983, 105, 492.
33. Ogino, A.; Matsumura, S.; Fujita, T.; J. Med. Chem. 1980, 23, 437.
34. Goto, M.; In : Tahenryo Deta uo Kaisekiho (The multivariate analysis); 1973, Kagakijohosha, Osaka, p157 .
35. Mizuta, E.; Suzuki, N.; Miyake, Y.; Nishikawa, M.; Fujita, T.; Chem. Pharm. Bull. 1975, 23, 5.
36. Free, Jr., S.H.; Wilson, J.W.; J. Med. Chem., 1964, 7, 395.
37. Fujita, T.; Ban, T.; J. Med. Chem., 1971, 14, 148.
38. Hsuanyu, y.; Dunford, N.B.; J. Biol. Chem., 1992, 267, 17649.
39. Naito, Y.; Yamaura, Y.; Inone, Y.; Fukaya, C.; Yokoyama, K.; Nakagawa, Y.; Fujita, T ; Eur. J. Med. Chem, 1992, 27, 645.
40. Terada, H.; Muraoka, S.; Fujita, T.; J. Med. Chem., 1974, 17, 330.
41. Nakaue, H.S.; Caldwell, R.S.; Buhler, D.R.; Biochem. Phamacol. , 1972, 21, 2273.
42. Leo, A.J.; Hansch, C.; Eldkins, D.; Chem. Rev., 1971, 71, 525.
43. Vandenbelt, J.M.; Hansch, C.; Church, C.; J. Med. Chem. 1972, 15, 787.
44. Hansch, C.; Dunn, W.J.; J. Pharm. Sci. 1972, 61, 1.
45. Rahim, S.; Aubry, A F.; J. Pharm. Sci. 1995, 84, 949.
46. Smeyers, Y.G.; Bouniam, L.; Smeyers, N.J.; Ezzamarty, A.; Hernandez, Laguma, A.; Sainz-Diaz, C.I.; Eur. J. Med. Chem., 1998, 33, 103.
47. Wilkerson, W.; Delucca, I.; Galbraith, W.; Kerr, J.; Eur. J. Med. Chem. 1992, 27, 595.
48. cv : is the average residual standard error of estimation of the predicted potency from the leave-one -out validation analysis calculated from the corresponding PRESS (Predictive REsidual Sum of Squares) value.